A multicenter, single-blind, randomized, warfarin-controlled trial of edoxaban in patients with chronic thromboembolic pulmonary hypertension: KABUKI trial - Hosokawa, K; Watanabe, H; Taniguchi, Y (Circulation, 2024)
et al.